Cryptococcal Meningitis Guidelines 2024. The new guidelines include a discussion of the management of cryptococcal meningoencephalitis in three risk groups: Cryptococcal meningitis is the most frequent manifestation of cryptococcosis.
These guidelines provide recommendations and good practice guidance on the optimal approach to diagnosing cryptococcal meningitis, strategies for preventing invasive. In response to important new evidence that became available in 2021, these new guidelines strongly recommend a single high dose of liposomal amphotericin b as part of the preferred induction regimen for the treatment of cryptococcal meningitis in people.